National Institutes of Health researchers develop eye drops that slow vision loss in animals: Maryland Monday, March 24, 2025, 16:00 Hrs [IST] Researchers at the National Institut ...

Learn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.

Biomea Fusion (BMEA) announced the presentation of preclinical and clinical data from studies assessing icovamenib at the Advanced Technologies ...

With promising results in animal models, researchers are now planning clinical trials to evaluate the safety and ...

One of the most buzz-worthy skincare ingredients at the moment is all about plumping and replenishing the skin: peptides.

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

Too Faced's Better Than Sex mascara is an iconic high-end mascara, not just for its brow-raising name but for its ...

Explore the potential of Compound X in combating skin aging by boosting collagen and reducing inflammation effectively.

Researchers conducted a randomized clinical trial examining the effects of semaglutide in non-treatment-seeking adults with alcohol-use disorder.

Master these expert eyebrow shaping techniques to transform your face instantly with professional-looking results that last ...

Novo Nordisk (NVO) secured exclusive global rights to United Laboratories International's therapeutic candidate for obesity and type 2 diabetes in a licensing deal worth up to $2 billion. The product ...

GLP-1 weight loss drugs cost CT’s Medicaid program $85 million in FY 2024, 35% of annual Medicaid pharmaceutical budget ...